{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:20:49Z","timestamp":1740183649490,"version":"3.37.3"},"reference-count":51,"publisher":"Elsevier BV","issue":"02","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003062","name":"Erciyes University","doi-asserted-by":"crossref","award":["TYL-2016\u20136956"],"award-info":[{"award-number":["TYL-2016\u20136956"]}],"id":[{"id":"10.13039\/501100003062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glob Med Genet"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer's disease (AD) is a neurodegenerative disease that is characterized by a devastating decline in cognitive activities among all types of dementia, and it severely affects the quality of life. Late-onset AD (LOAD) occurs after the age of 65 years and develops sporadically. Although aging comes first along the main risk factors underlying LOAD, disease-causing susceptibility genes have been associated with disease pathogenesis. In our study, we included the genes PARP1, POLB, HTRA2, SLC1A2, HS1BP3, and DRD3 to be investigated in LOAD patients based on their expression levels. Within this framework, we aimed to determine the possible functions of these genes in the pathophysiology of the disease. We investigated whether the utilization of these genes as biomarkers in the early diagnosis of LOAD may help the treatment scheme to be applied in the clinic. We involved 50 individuals in the study and collected peripheral blood samples from the patients and control groups for molecular genetic analysis. Subsequently, RNA was extracted from the peripheral blood samples, and expression analyzes were performed using qualitative reverse transcription polymerase chain reaction. The results obtained were evaluated by using proper statistical methods. Our results demonstrated that there was no difference between patient and control groups in terms of HTRA2, DRD3, HS1BP3, and POLB genes. The expression levels of the SLC1A2 and PARP1 genes were significantly lower in the patient group compared with the control group. In conclusion, we presume that the PARP1 and SLC1A2 genes can be utilized as molecular biomarkers for LOAD.<\/jats:p>","DOI":"10.1055\/s-0042-1743570","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:22:37Z","timestamp":1646785357000},"page":"110-117","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease"],"prefix":"10.1016","volume":"09","author":[{"given":"Sercan","family":"Kenanoglu","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nefise","family":"Kandemir","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey"},{"name":"Department of Medical Genetics, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Akalin","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye","family":"Gokce","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet F.","family":"Gol","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emel","family":"Koseoglu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Mirza","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munis","family":"Dundar","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"issue":"02","key":"ref1","first-page":"1","article-title":"New insights into the molecular bases of familial Alzheimer's disease","volume":"10","author":"V D'Argenio","year":"2020","journal-title":"J Pers Med"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms21061989","article-title":"Biochemical markers in Alzheimer's disease","volume":"21","author":"A Rabbito","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/07853890802186905","article-title":"Molecular genetics of Alzheimer's disease: an update","volume":"40","author":"N Brouwers","year":"2008","journal-title":"Ann Med"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1002\/jcp.28372","article-title":"Genetic discoveries and advances in late-onset Alzheimer's disease","volume":"234","author":"M Rezazadeh","year":"2019","journal-title":"J Cell Physiol"},{"issue":"09","key":"ref5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/neu.2007.0456","article-title":"Apolipoprotein E3\/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: preliminary data","volume":"25","author":"F Tanriverdi","year":"2008","journal-title":"J Neurotrauma"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/CIA.S105769","article-title":"Genes associated with Alzheimer's disease: an overview and current status","volume":"11","author":"M Giri","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"S 01","key":"ref7","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.copbio.2013.05.011","article-title":"Progress towards the \u2018Golden Age\u2019 of biotechnology","volume":"24","author":"K MA Gartland","year":"2013","journal-title":"Curr Opin Biotechnol"},{"issue":"18","key":"ref8","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1111\/j.1742-4658.2005.04864.x","article-title":"Poly(ADP-ribose). The most elaborate metabolite of NAD+","volume":"272","author":"A B\u00fcrkle","year":"2005","journal-title":"FEBS J"},{"issue":"08","key":"ref9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bies.20085","article-title":"The PARP superfamily","volume":"26","author":"J C Am\u00e9","year":"2004","journal-title":"BioEssays"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.18632\/oncotarget.6849","article-title":"R152C DNA Pol \u03b2 mutation impairs base excision repair and induces cellular transformation","volume":"7","author":"T Zhou","year":"2016","journal-title":"Oncotarget"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1128\/MCB.24.22.9848-9862.2004","article-title":"Neuroprotective role of the Reaper-related serine protease HtrA2\/Omi revealed by targeted deletion in mice","volume":"24","author":"L M Martins","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"16","key":"ref12","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","article-title":"Toxic proteins released from mitochondria in cell death","volume":"23","author":"X Saelens","year":"2004","journal-title":"Oncogene"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-142304","article-title":"Partial loss of the glutamate transporter glt-1 alters brain akt and insulin signaling in a mouse model of Alzheimer's disease","volume":"45","author":"K D Meeker","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.20692","article-title":"HS1-BP3 gene variant is common in familial essential tremor","volume":"21","author":"J J Higgins","year":"2006","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"13889","DOI":"10.1038\/ncomms13889","article-title":"HS1BP3 negatively regulates autophagy by modulation of phosphatidic acid levels","volume":"7","author":"P Holland","year":"2016","journal-title":"Nat Commun"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/15548627.2017.1305534","article-title":"HS1BP3 provides a novel mechanism of negative autophagy regulation through membrane lipids","volume":"13","author":"Z Yin","year":"2017","journal-title":"Autophagy"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-2009-1054","article-title":"Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type","volume":"17","author":"N Sato","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"03","key":"ref18","first-page":"189","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"M F Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"prot5439","DOI":"10.1101\/pdb.prot5439","article-title":"Purification of RNA using TRIzol (TRI reagent)","volume":"2010","author":"D C Rio","year":"2010","journal-title":"Cold Spring Harb Protoc"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12031-019-01420-x","article-title":"ABCA7 and EphA1 genes polymorphisms in late-onset Alzheimer's disease","volume":"70","author":"M Talebi","year":"2020","journal-title":"J Mol Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"l6217","DOI":"10.1136\/bmj.l6217","article-title":"Cognitive symptoms of Alzheimer's disease: clinical management and prevention","volume":"367","author":"E Joe","year":"2019","journal-title":"BMJ"},{"issue":"08","key":"ref22","doi-asserted-by":"crossref","first-page":"1849.e5","DOI":"10.1016\/j.neurobiolaging.2012.02.014","article-title":"Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS)","volume":"33","author":"H Shi","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","article-title":"Genetics of Alzheimer's disease: where we are, and where we are going","volume":"61","author":"C Bellenguez","year":"2020","journal-title":"Curr Opin Neurobiol"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096504016X14666990347554","article-title":"Knockdown of PARP-1 inhibits proliferation and ERK signals, increasing drug sensitivity in osteosarcoma U2OS cells","volume":"24","author":"S Li","year":"2016","journal-title":"Oncol Res"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sbi.2013.01.003","article-title":"PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis","volume":"23","author":"M F Langelier","year":"2013","journal-title":"Curr Opin Struct Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1126\/science.aad8242","article-title":"A conserved NAD+ binding pocket that regulates protein-protein interactions during aging","volume":"355","author":"J Li","year":"2017","journal-title":"Science"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13041-016-0237-z","article-title":"Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease","volume":"9","author":"M S Lillenes","year":"2016","journal-title":"Mol Brain"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease","volume":"93","author":"J Wang","year":"2005","journal-title":"J Neurochem"},{"issue":"09","key":"ref29","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.neurobiolaging.2011.08.009","article-title":"Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease","volume":"33","author":"K J Krishnan","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.neurobiolaging.2014.01.004","article-title":"Base excision DNA repair levels in mitochondrial lysates of Alzheimer's disease","volume":"35","author":"C Canugovi","year":"2014","journal-title":"Neurobiol Aging"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neurobiolaging.2018.09.015","article-title":"Lower mitochondrial DNA content but not increased mutagenesis associates with decreased base excision repair activity in brains of AD subjects","volume":"73","author":"D T Soltys","year":"2019","journal-title":"Neurobiol Aging"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s004010100418","article-title":"Expression of 8-oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer's disease brain","volume":"103","author":"T Iida","year":"2002","journal-title":"Acta Neuropathol"},{"issue":"16","key":"ref33","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1093\/nar\/gkm605","article-title":"Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment","volume":"35","author":"L Weissman","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-8993(99)02335-5","article-title":"Decreased base excision repair and increased helicase activity in Alzheimer's disease brain","volume":"855","author":"M A Lovell","year":"2000","journal-title":"Brain Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0079-6603(01)68090-5","article-title":"Mammalian DNA \u03b2-polymerase in base excision repair of alkylation damage","volume":"68","author":"R W Sobol","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"e0221362","DOI":"10.1371\/journal.pone.0221362","article-title":"Investigation of base excision repair gene variants in late-onset Alzheimer's disease","volume":"14","author":"T Ertuzun","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mad.2013.09.002","article-title":"Transient OGG1, APE1, PARP1 and Pol\u03b2 expression in an Alzheimer's disease mouse model","volume":"134","author":"M S Lillenes","year":"2013","journal-title":"Mech Ageing Dev"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/acel.12541","article-title":"DNA polymerase \u03b2 decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease","volume":"16","author":"M Misiak","year":"2017","journal-title":"Aging Cell"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/nar\/gku1356","article-title":"DNA polymerase \u03b2 deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes","volume":"43","author":"P Sykora","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.cdd.4401343","article-title":"Mitochondrial protease Omi\/HtrA2 enhances caspase activation through multiple pathways","volume":"11","author":"Y Suzuki","year":"2004","journal-title":"Cell Death Differ"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.cdd.4400970","article-title":"The serine protease Omi\/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity","volume":"9","author":"G van Loo","year":"2002","journal-title":"Cell Death Differ"},{"issue":"07","key":"ref42","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1007\/s12035-018-1383-3","article-title":"Increased active OMI\/HTRA2 serine protease displays a positive correlation with cholinergic alterations in the Alzheimer's disease brain","volume":"56","author":"T Darreh-Shori","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.10-163402","article-title":"Altered enzymatic activity and allele frequency of OMI\/HTRA2 in Alzheimer's disease","volume":"25","author":"M Westerlund","year":"2011","journal-title":"FASEB J"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbrc.2007.07.118","article-title":"Transgenic mice with neuron-specific overexpression of HtrA2\/Omi suggest a neuroprotective role for HtrA2\/Omi","volume":"362","author":"M J Liu","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fpsyt.2018.00561","article-title":"Elevated glutamate and glutamine levels in the cerebrospinal fluid of patients with probable Alzheimer's disease and depression","volume":"9","author":"C Madeira","year":"2018","journal-title":"Front Psychiatry"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"553.e1","DOI":"10.1016\/j.neurobiolaging.2010.03.008","article-title":"Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease","volume":"32","author":"H A Scott","year":"2011","journal-title":"Neurobiol Aging"},{"issue":"18","key":"ref47","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1523\/JNEUROSCI.23-18-07176.2003","article-title":"Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1","volume":"23","author":"A Mitani","year":"2003","journal-title":"J Neurosci"},{"issue":"08","key":"ref48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"R A Nixon","year":"2013","journal-title":"Nat Med"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-019-1652-8","article-title":"Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation","volume":"16","author":"A Montoya","year":"2019","journal-title":"J Neuroinflammation"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-0173(99)00043-0","article-title":"Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions","volume":"31","author":"J C Schwartz","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.18051\/UnivMed.2020.v39.105-112","article-title":"Propranolol decreases DRD3 and SLC1A2 gene expression in patients with essential tremor","volume":"39","author":"N Kandemir","year":"2020","journal-title":"Universa Med"}],"container-title":["Global Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1743570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:22:40Z","timestamp":1736436160000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1743570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":51,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1743570","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2699-9404"],"issn-type":[{"type":"electronic","value":"2699-9404"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}